Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,542 | 626 | 93.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $487.67 | 1 | 3.6% |
| Honoraria | $350.00 | 1 | 2.6% |
| Education | $32.35 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,353 | 149 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,109 | 46 | $0 (2024) |
| Biofrontera Inc. | $1,106 | 12 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $1,054 | 8 | $0 (2020) |
| LEO Pharma Inc. | $886.85 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $863.75 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $613.51 | 33 | $0 (2024) |
| Lilly USA, LLC | $528.29 | 17 | $0 (2024) |
| Galderma Laboratories, L.P. | $475.65 | 29 | $0 (2024) |
| GENZYME CORPORATION | $430.79 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,983 | 106 | ABBVIE INC. ($515.70) |
| 2023 | $1,635 | 92 | AbbVie Inc. ($390.05) |
| 2022 | $1,403 | 78 | ABBVIE INC. ($397.72) |
| 2021 | $1,205 | 65 | Regeneron Healthcare Solutions, Inc. ($248.33) |
| 2020 | $913.79 | 44 | AbbVie Inc. ($179.54) |
| 2019 | $2,238 | 87 | Merz North America, Inc. ($691.90) |
| 2018 | $1,535 | 75 | Merz North America, Inc. ($218.56) |
| 2017 | $2,500 | 83 | Biofrontera Inc. ($973.96) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.52 | General |
| Category: Immunology | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $43.48 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.84 | General |
| Category: Immunology | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.66 | General |
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,853 | 9,731 | $1.7M | $304,650 |
| 2022 | 29 | 4,236 | 17,035 | $1.7M | $364,184 |
| 2021 | 31 | 4,526 | 21,596 | $1.9M | $413,216 |
| 2020 | 32 | 4,542 | 16,423 | $1.8M | $362,840 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,168 | 1,955 | $514,165 | $114,918 | 22.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 536 | 715 | $270,270 | $46,219 | 17.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 605 | 840 | $255,049 | $29,593 | 11.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 298 | 338 | $141,622 | $27,503 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 176 | $65,472 | $15,318 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 182 | 330 | $67,650 | $12,981 | 19.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 47 | 55 | $55,110 | $12,426 | 22.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 394 | 1,343 | $112,812 | $6,786 | 6.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 45 | $31,315 | $5,609 | 17.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $23,433 | $4,777 | 20.4% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 16 | 3,400 | $6,840 | $4,346 | 63.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 37 | 41 | $38,382 | $3,995 | 10.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 17 | 17 | $11,414 | $3,574 | 31.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 39 | 39 | $14,388 | $3,487 | 24.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 68 | 77 | $11,360 | $2,957 | 26.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 23 | 25 | $26,554 | $2,778 | 10.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 48 | 63 | $12,712 | $1,906 | 15.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 20 | $9,500 | $1,806 | 19.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 16 | 17 | $8,415 | $1,786 | 21.2% |
| 69100 | Biopsy of ear | Office | 2023 | 30 | 31 | $21,005 | $1,688 | 8.0% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 16 | 20 | $1,194 | $114.22 | 9.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 49 | 111 | $1,813 | $84.94 | 4.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,194 | 1,975 | $372,327 | $116,008 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 572 | 753 | $215,983 | $49,345 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 599 | 834 | $253,227 | $30,102 | 11.9% |
About Dr. Gregory Cox, MD
Dr. Gregory Cox, MD is a Dermatology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306803796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Cox, MD has received a total of $13,412 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 630 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($12,542).
As a Medicare-enrolled provider, Cox has provided services to 17,157 Medicare beneficiaries, totaling 64,785 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Atlanta, GA
- Active Since 04/28/2006
- Last Updated 02/15/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1306803796
Products in Payments
- DUPIXENT (Biological) $1,154
- Ameluz (Drug) $973.96
- SKYRIZI (Biological) $783.04
- RINVOQ (Biological) $676.43
- ADBRY (Biological) $610.48
- Otezla (Drug) $561.44
- Humira (Biological) $529.16
- COSENTYX (Biological) $406.64
- TREMFYA (Drug) $377.74
- TALTZ (Drug) $376.45
- OPZELURA (Drug) $359.53
- EUCRISA (Drug) $255.69
- DUPIXENT DUPILUMAB INJECTION (Biological) $248.74
- Tremfya (Drug) $245.37
- DORYX (Drug) $238.19
- VTAMA (Drug) $217.70
- ENSTILAR (Drug) $206.29
- Skyrizi (Biological) $149.72
- SILIQ (Drug) $149.54
- REMICADE (Biological) $136.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Atlanta
Dr. Zakiya Rice, Md, MD
Dermatology — Payments: $920,568
Dr. Mack Rachal, M.d, M.D
Dermatology — Payments: $478,485
Dr. Anna Pare', M.d, M.D
Dermatology — Payments: $54,847
Sarah Chisolm, M.d, M.D
Dermatology — Payments: $44,095
Ron Feldman, Md, Phd, MD, PHD
Dermatology — Payments: $38,217
Lauren Orenstein, Md, MD
Dermatology — Payments: $27,645